Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

UNVEIL-BPO Median Lobe Study: An International Multicenter Evaluation of Selective Median Lobe Resection and Enucleation

NCT07699718 is registered in ClinicalTrials.gov with Necmettin Erbakan University as lead sponsor.

NCT NCT07699718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07699718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
UNVEIL-BPO Median Lobe Study: An International Multicenter Evaluation of Selective Median Lobe Resection and Enucleation
Lead sponsor
Necmettin Erbakan University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 1, 2030
Enrollment
420 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, benign prostatic obstruction, lower urinary tract symptoms (luts) in men with benign prostatic hyperplasia (bph), median lobe prostatic enlargement, urinary retention